Treatment outcomes in patients with proven/probable vs possible invasive mould disease in a phase III trial comparing isavuconazole vs voriconazole
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment outcomes in patients with proven/probable vs possible invasive mould disease in a phase III trial comparing isavuconazole vs voriconazole
Authors
Keywords
-
Journal
MYCOSES
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-07-23
DOI
10.1111/myc.12831
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Isavuconazole for treatment of rare invasive fungal diseases
- (2018) Oliver A. Cornely et al. MYCOSES
- Isavuconazole treatment for rare fungal diseases and for invasive aspergillosis in patients with renal impairment: Challenges and lessons of the VITAL trial
- (2018) John R. Perfect et al. MYCOSES
- Isavuconazole for treatment of invasive fungal diseases caused by more than one fungal species
- (2018) Francisco M. Marty et al. MYCOSES
- Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses
- (2016) George R. Thompson et al. CLINICAL INFECTIOUS DISEASES
- Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
- (2016) Thomas F. Patterson et al. CLINICAL INFECTIOUS DISEASES
- Dose-Dependent Bioavailability and CYP3A Inhibition Contribute to Non-Linear Pharmacokinetics of Voriconazole
- (2016) Nicolas Hohmann et al. CLINICAL PHARMACOKINETICS
- ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients
- (2016) Frederic Tissot et al. HAEMATOLOGICA
- Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial
- (2016) Johan A Maertens et al. LANCET
- Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis
- (2016) Francisco M Marty et al. LANCET INFECTIOUS DISEASES
- ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients
- (2016) Frederic Tissot et al. HAEMATOLOGICA
- Incidence and characteristics of invasive fungal diseases in allogeneic hematopoietic stem cell transplant recipients: a retrospective cohort study
- (2015) Nicole Harrison et al. BMC INFECTIOUS DISEASES
- Isavuconazole: A New Broad-Spectrum Triazole Antifungal Agent
- (2015) Marisa H. Miceli et al. CLINICAL INFECTIOUS DISEASES
- Immune Reconstitution After Allogeneic Hematopoietic Stem Cell Transplantation and Association With Occurrence and Outcome of Invasive Aspergillosis
- (2015) Claudia Stuehler et al. JOURNAL OF INFECTIOUS DISEASES
- Invasive Aspergillosis: Epidemiology, Clinical Aspects, and Treatment
- (2015) Carol Kauffman et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- Application of the 2008 Definitions for Invasive Fungal Diseases to the Trial Comparing Voriconazole Versus Amphotericin B for Therapy of Invasive Aspergillosis: A Collaborative Study of the Mycoses Study Group (MSG 05) and the European Organization for Research and Treatment of Cancer Infectious Diseases Group
- (2014) Raoul Herbrecht et al. CLINICAL INFECTIOUS DISEASES
- Voriconazole pharmacokinetics and exposure–response relationships: Assessing the links between exposure, efficacy and toxicity
- (2014) Michael J. Dolton et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Aspergillosis in Solid Organ Transplantation
- (2013) N. M. Singh et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005–2007)
- (2011) O. Lortholary et al. CLINICAL MICROBIOLOGY AND INFECTION
- Efficacy outcomes in a randomised trial of liposomal amphotericin B based on revised EORTC/MSG 2008 definitions of invasive mould disease
- (2010) Oliver A. Cornely et al. MYCOSES
- Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients
- (2010) D. Neofytos et al. Transplant Infectious Disease
- Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
- (2008) Ben De Pauw et al. CLINICAL INFECTIOUS DISEASES
- Epidemiology and Outcome of Invasive Fungal Infection in Adult Hematopoietic Stem Cell Transplant Recipients: Analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance Registry
- (2008) D. Neofytos et al. CLINICAL INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now